Side-by-side comparison of AI visibility scores, market position, and capabilities
Smart home security camera company with $530M revenue; wire-free battery cameras with AI object detection and Arlo Secure subscription competing with Ring and Nest cameras.
Arlo Technologies is a smart home security camera company producing wire-free, battery-powered outdoor and indoor security cameras with AI-powered motion detection, object recognition (person, vehicle, animal, package), and cloud video storage subscription services. Originally a division of Netgear and spun off as an independent public company in 2018, Arlo is listed on NYSE (NYSE: ARLO) and headquartered in San Jose, California, generating approximately $530 million in annual revenue with a growing base of paid Secure subscription subscribers.\n\nArlo's product lineup features the Arlo Ultra 4K cameras, Arlo Pro series (weatherproof, wire-free, rechargeable battery), Arlo Doorbell, Arlo Floodlight, and Arlo Video Doorbell. The wire-free design (using rechargeable batteries rather than power wiring) is Arlo's key differentiation — easy DIY installation anywhere without electrician work. Arlo Secure subscription plans provide cloud video history (30 days), AI-powered person, vehicle, and package detection, emergency response dispatch (for alarm systems), and Arlo's end-to-end encrypted video storage.\n\nIn 2025, Arlo competes with Ring (Amazon), Google Nest, Eufy (Anker), and Wyze for home security camera market share. The smart home security camera market has matured with intense competition from vertically integrated players (Amazon's Ring subsidized through Prime ecosystem, Google's Nest) and ultra-low-cost brands (Wyze cameras at $25-40). Arlo's premium pricing ($200-600 for cameras) is under pressure, and the company has focused on growing its subscription Secure revenue as the primary business model metric. The 2025 strategy focuses on growing Arlo Secure paid subscribers, launching new integrated home security alarm products, and improving AI detection accuracy to reduce false motion alerts.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.